Company intelligence / Profile preview

Seigla Medical

Buffalo, Minnesota, United Statesseiglamedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Seigla Medical has developed and commercialized the LiquID Guide Catheter Extension device, which features a larger intraluminal diameter and thinner wall compared to predicate devices. The product has received FDA clearance via the 510(k) pathway as a Class II percutaneous catheter. It supports improved outcomes in complex PCI by enabling radial access with enhanced lumen size and flexibility[2][3].

Therapeutic areas: CardiovascularNeurology
Modalities: Device (specifically guide catheter extension devices)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Seigla Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seigla Medical.

Explore the full profile